Bestell- und Beratungshotline
Tel.: +49 (0)221 788 748-11
E-Mail: service[at]marktforschung.de

Tools
Werbung:
Marktanalyse - Strong Pipeline Characterized with Novel Therapies will Drive the Methicillin-Resistant Staphylococcus Aureus (MRSA) Market
GlobalData
2 / 2011
5 Seiten
| Typ: | Marktanalyse |
| Sprache: | Englisch |
| Regionen: | Europa, Asien / Pazifik, Mittlerer Osten / Afrika, Nordamerika / USA, Australien, Mittel- / Südamerika |
| Verfügbarkeit: | verfügbar |
Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:
Strong Pipeline Characterized with Novel Therapies will Drive the Methicillin-Resistant Staphylococcus Aureus (MRSA) Market
Summary
GlobalData’s report, 'Strong Pipeline Characterized with Novel Therapies will drive the Methicillin-Resistant Staphylococcus Aureus (MRSA) Market” provides key information on current available treatment of MRSA and how the novel pipeline molecules will drive the global market of MRSA.
Scope
- Data and information on noval therapy on MRSA market
Reasons to buy
- Develop business strategies by understanding the trends and developments in MRSA Market
Summary
GlobalData’s report, 'Strong Pipeline Characterized with Novel Therapies will drive the Methicillin-Resistant Staphylococcus Aureus (MRSA) Market” provides key information on current available treatment of MRSA and how the novel pipeline molecules will drive the global market of MRSA.
Scope
- Data and information on noval therapy on MRSA market
Reasons to buy
- Develop business strategies by understanding the trends and developments in MRSA Market
1 Table of Contents
1 Table of Contents 1
1.1 List of tables 1
2 Summary 1
3 Overview 1
3.1 Classification of MRSA 2
3.1.1 Hospital-acquired Methicillin-Resistant Staphylococcus Aureus (HA-MRSA): 2
3.1.2 Community-acquired Methicillin-Resistant Staphylococcus Aureus (CA-MRSA): 2
3.2 Current Treatment Paradigm 2
3.2.1 Specific drug therapy 2
3.3 Major Market Product 3
3.4 MRSA Market: Oppourtunity and Unmeet Need 3
3.5 Methicillin-resistant Staphylococcus aureus Market — Most Promising Drugs under Clinical Development 4
4 Appendix 4
4.1 Methodology 4
4.1.1 Coverage 4
4.1.2 Secondary Research 5
4.1.3 Primary Research 5
4.1.4 Expert Panel Validation 5
4.2 Contact Us 5
4.3 Disclaimer 5
1.1 List of Tables
Table 1: Major Marketed Products Comparison in MRSA Therapeutics Market, 2010 3
Table 2: MRSA Therapeutics Market — Most Promising Drugs Under Clinical Development, 2010 4
1 Table of Contents 1
1.1 List of tables 1
2 Summary 1
3 Overview 1
3.1 Classification of MRSA 2
3.1.1 Hospital-acquired Methicillin-Resistant Staphylococcus Aureus (HA-MRSA): 2
3.1.2 Community-acquired Methicillin-Resistant Staphylococcus Aureus (CA-MRSA): 2
3.2 Current Treatment Paradigm 2
3.2.1 Specific drug therapy 2
3.3 Major Market Product 3
3.4 MRSA Market: Oppourtunity and Unmeet Need 3
3.5 Methicillin-resistant Staphylococcus aureus Market — Most Promising Drugs under Clinical Development 4
4 Appendix 4
4.1 Methodology 4
4.1.1 Coverage 4
4.1.2 Secondary Research 5
4.1.3 Primary Research 5
4.1.4 Expert Panel Validation 5
4.2 Contact Us 5
4.3 Disclaimer 5
1.1 List of Tables
Table 1: Major Marketed Products Comparison in MRSA Therapeutics Market, 2010 3
Table 2: MRSA Therapeutics Market — Most Promising Drugs Under Clinical Development, 2010 4
- Calming and Sleeping in Argentina
- Calming and Sleeping in Canada
- Calming and Sleeping in Denmark
- Calming and Sleeping in Guatemala
- Calming and Sleeping in Hong Kong, China
- Calming and Sleeping in Norway
- Calming and Sleeping in Turkey
- Cough, Cold and Allergy (Hay Fever) Remedies in Argentina
- Cough, Cold and Allergy (Hay Fever) Remedies in Canada
- Cough, Cold and Allergy (Hay Fever) Remedies in Denmark
- Cough, Cold and Allergy (Hay Fever) Remedies in Guatemala
- Cough, Cold and Allergy (Hay Fever) Remedies in Hong Kong, China
- Cough, Cold and Allergy (Hay Fever) Remedies in Norway
- Cough, Cold and Allergy (Hay Fever) Remedies in Tunisia
- Cough, Cold and Allergy (Hay Fever) Remedies in Turkey
- Critical Care Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for Albumin in Asia-Pacific
- Ear Care in Argentina
- Ear Care in Canada
- Ear Care in Denmark
- Ear Care in Hong Kong, China
*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.
Hinweise: **The report can be shared by users within one office (one geographical location)
***Across Geographical locations (by the purchasing company only)
Für Sie protokollierte Studien / Marktanalysen:
zuletzt angesehene Studien:

